L'Oreal Doubles Stake in Swiss Skincare Company Galderma

Dow Jones

2025/12/08

By Sarah Sloat

L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology.

Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said.

The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year.

The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion.

L'Oreal said it wasn't planning to further increase its stake.

Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table.

Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT.

Write to Sarah Sloat at sarah.sloat@wsj.com

(END) Dow Jones Newswires

December 08, 2025 04:17 ET (09:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2589333527"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2589333527\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2589333527?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 17:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589333527","market":"fut","top_or_hot":-1,"title":"L'Oreal Doubles Stake in Swiss Skincare Company Galderma","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Sarah Sloat \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n</p>\n<p>\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n</p>\n<p>\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. skincare brand, earlier this year. \n</p>\n<p>\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n</p>\n<p>\n  L'Oreal said it wasn't planning to further increase its stake. \n</p>\n<p>\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n</p>\n<p>\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 04:17 ET (09:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>L'Oreal Doubles Stake in Swiss Skincare Company Galderma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nL'Oreal Doubles Stake in Swiss Skincare Company Galderma\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-12-08 17:17</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Sarah Sloat \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n</p>\n<p>\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n</p>\n<p>\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.<a href=\"https://laohu8.com/S/TKKD.SI\">K</a>. skincare brand, earlier this year. \n</p>\n<p>\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n</p>\n<p>\n  L'Oreal said it wasn't planning to further increase its stake. \n</p>\n<p>\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n</p>\n<p>\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 08, 2025 04:17 ET (09:17 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4183","symbol_name":"個人用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2589333527","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589333527","pubTimestamp":1765185420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology.Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs  based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said.The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year.The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The com","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4183":"个人用品","BK6100":"保健护理服务","LRLCY":"欧莱雅"},"translate_title":"欧莱雅将瑞士护肤品公司Galderma的股份增加一倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NPL.SI":1.5,"LRLCY":0.9},"content_text":"By Sarah Sloat \n\n\n \n\n\n  L'Oreal is buying a stake in Galderma from an investor group, doubling its holding in the Swiss company to 20% in a deal that expands its footprint in dermatology. \n\n\n  Financial terms weren't disclosed. The package of about 24 million Galderma shares would be valued at 3.9 billion francs ($4.85 billion) based on Friday's closing price of 162.80 francs. The seller is an investment group led by Sweden's EQT and includes Sunshine SwissCo, Abu Dhabi Investment Authority and Auba Investment, L'Oreal said. \n\n\n  The deal deepens L'Oreal's footprint in skincare, having agreed to buy South Korean skincare brand Dr.G last December, and signing a deal to acquire a majority stake in Medik8, a U.K. skincare brand, earlier this year. \n\n\n  The French cosmetics group, whose brands include Maybelline, Aesop and Lancome, founded Galderma with Nestle more than 40 years ago. After exiting the company in 2014, it returned to buy a 10% stake in 2024. Galderma focuses on injectable aesthetics and dermatological skincare treatments. The company, which went public in 2024, had net sales in 2024 of $4.4 billion. \n\n\n  L'Oreal said it wasn't planning to further increase its stake. \n\n\n  Analysts at Vontobel said the deal makes strategic sense for L'Oreal, with Galderma bringing scientific leadership in dermatology to the table. \n\n\n  Galderma said it would consider putting two L'Oreal representatives on its board, replacing those representing the consortium led by EQT. \n\n\n \n\n\n  Write to Sarah Sloat at sarah.sloat@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 08, 2025 04:17 ET (09:17 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}